DOSIERVORRICHTUNG

European patent · EP1250572 · Deleted

Register entry

Publication number
EP1250572
Application number
EP01911539
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Jan 26, 2001
Published
Oct 23, 2002
Granted
Apr 22, 2009
Deleted
Jan 31, 2010
Reason
Annual fee unpaid
IPC classes
G01F 11/02 (2006.01)
Priority
GB 0002095 28.01.2000
PCT application
PCT/EP2001/000860 26.01.2001
PCT publication
WO2001/055681 02.08.2001
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 18, 2010

    Deleted, fee unpaid

    Published in Swissreg on 18.08.2010

  2. Apr 22, 2009

    Granted

    Published in Swissreg on 22.04.2009

Parties

Holder

Novartis AG

NOVARTIS AG

Lichtstrasse 35, 4056 Basel

Inventor

PRICE, Phil, T.

Oxford OX3 7EX, GB

BLEY, Stephanie

CH-4057 Basel

SAMS, Bernard

London N12 8EJ, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.